Open AccessUse of endobronchial valve to treat COVID-19 adult respiratory distress syndrome-related alveolopleural fistula
Author(s) -
Vikas Pathak,
John Barker Waite,
Som N Chalise
Publication year - 2021
Publication title -
lung india
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 25
eISSN - 0974-598X
pISSN - 0970-2113
DOI - 10.4103/lungindia.lungindia_914_20
Subject(s) - medicine , ards , mechanical ventilation , pneumonia , covid-19 , respiratory failure , respiratory distress , fistula , airway , diffuse alveolar damage , complication , intubation , surgery , intensive care medicine , anesthesia , acute respiratory distress , lung , disease , infectious disease (medical specialty)
Coronavirus disease-2019 (COVID-19) pneumonia is one of the severe and most dreaded forms of illness caused by severe acute respiratory syndrome coronavirus 2. It often progresses to respiratory failure and acute respiratory distress syndrome (ARDS) requiring mechanical ventilation. ARDS can lead to multiple complications while on mechanical ventilation due to positive airway pressures in a fibrotic lung, one such complication is the development of alveolopleural fistula. Alveolopleural fistula has high morbidity and mortality. We used endobronchial valve in a patient with COVID-19-related ARDS with persistent air leak (alveolopleural fistula), which allowed us to remove the chest tube and wean the patient successfully off mechanical ventilation.